Evidence map›Paper›PMID 36234598›Full record

ReviewNanomaterials (Basel, Switzerland)2022

Upconversion Nanomaterials in Bioimaging and Biosensor Applications and Their Biological Response.

Zayakhuu Gerelkhuu, Yong-Ill Lee, Tae Hyun Yoon

Open access · goldAbstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Zayakhuu GerelkhuuDepartment of Chemistry, College of Natural Sciences, Hanyang University, Seoul 04763, Korea.
Yong-Ill LeeDepartment of Materials Convergence and System Engineering, Changwon National University, Changwon 51140, Korea.ORCID 0000-0001-5383-9801
Tae Hyun YoonDepartment of Chemistry, College of Natural Sciences, Hanyang University, Seoul 04763, Korea.ORCID 0000-0002-2743-6360
Hanyang Cyber University · KRChangwon National University · KR

Funding

Hanyang University HY-201800000002385Institute of Information & Communications Technology Planning & Evaluation (IITP) grant funded by the Korean government (MSIT) (No.2020-0-01373, Artificial Intelligence Graduate School Program (Hanyang University)) and the research fund of Hanyang Univers 2020R1A6A1A06046728Institute of Information & Communications Technology Planning & Evaluation (IITP) grant funded by the Korean government (MSIT) (No.2020-0-01373, Artificial Intelligence Graduate School Program (Hanyang University)) and the research fund of Hanyang Univers HY-202100000670025Korea Basic Science Institute (National Research Facilities and Equipment Center) 2019R1A6C1030014
6 · The paper itself

Abstract

In recent decades, upconversion nanomaterials (UCNMs) have attracted considerable research interest because of their unique optical properties, such as large anti-Stokes shifts, sharp emissions, non-photobleaching, and long lifetime. These unique properties make them ideal candidates for unified applications in biomedical fields, including drug delivery, bioimaging, biosensing, and photodynamic therapy for specific cancers. This review describes the general mechanisms of upconversion, synthesis methods, and potential applications in biology and their biological responses. Additionally, the biological toxicity of UCNMs is explained and summarized with the associated intracellular association mechanisms. Finally, the prospects and future challenges of UCNMs at the clinical level in biological applications are described, along with a summary of opportunity for biological as well as clinical applications of UCNMs.

Indexed as

bioimagingbiological responsebiosensorlanthanide-based nanomaterialsupconversion nanomaterials

Identifiers

PMID36234598
PMCPMC9565472
OpenAlexW4303958934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.